This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Kayrros, National Institute of Health and Medical Research, Université Paris Descartes. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2026
Title: Jean Bastin: Innovator in Mitochondrial Energy Dysfunction Treatment
Introduction
Jean Bastin is a notable inventor based in Vitry sur Seine, France. He has made significant contributions to the field of medical research, particularly in the treatment of diseases related to mitochondrial energy dysfunction. His innovative approach combines existing compounds to enhance therapeutic outcomes.
Latest Patents
Jean Bastin holds a patent for the "Combination of bezafibrate and of resveratrol or resveratrol derivatives for the treatment and prevention of diseases involving a mitochondrial energy dysfunction." This invention focuses on the combined use of bezafibrate and resveratrol or its derivatives to treat diseases associated with mitochondrial energy dysfunction. The patent highlights the effectiveness of this combination in addressing moderate defects in β-oxidation of long-chain fatty acids and the respiratory chain of mitochondria.
Career Highlights
Throughout his career, Jean Bastin has worked with prestigious institutions such as Université Paris Descartes and the National Institute of Health and Medical Research. His work has been instrumental in advancing the understanding and treatment of mitochondrial disorders.
Collaborations
Jean has collaborated with notable colleagues, including Fatima Djouadi and Omar Dhobb. Their combined expertise has contributed to the success of his research and innovations.
Conclusion
Jean Bastin's contributions to the field of mitochondrial energy dysfunction treatment exemplify the impact of innovative thinking in medical research. His patent and collaborations reflect a commitment to improving health outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile